Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06835556 · ClinicalTrials.gov registry record · NA
Volatility in Paranoia (VIP) Trial: An RCT of Changes in Volatility With Psychotherapy
A NA study of Schizophrenia Disorders, sponsored by Vanderbilt University Medical Center.
- Recruiting
- Registry status
- NA
- Development phase
- 120
- Enrollment target
- 1
- Study location
NCT06835556 is a NA study of Schizophrenia Disorders that is actively recruiting participants, run by Vanderbilt University Medical Center. The registered enrollment target is 120 participants, roughly in line with the 116-participant average among 5 other Schizophrenia Disorders trials with a reported enrollment target. The trial reports 1 study location across 1 state.
The verdict
NCT06835556, a NA study of Schizophrenia Disorders, is actively recruiting participants, sponsored by Vanderbilt University Medical Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 120 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to learn whether learning and belief updating change in response to the treatment of persecutory delusions, in individuals with schizophrenia-spectrum disorders. The main questions are: 1. do prior expectations about environmental volatility reduce following effective psychotherapeutic treatment of delusions? 2. does corresponding brain activity related to volatility change with effective treatment of delusions? Participants will: 1. engage in CBTp or TAU + phone check-ins for 16 weeks 2. complete assessments at 4 timepoints over the course of 6 months 3. complete an MRI when possible
Conditions Studied
Interventions
- BEHAVIORAL Cognitive Behavioral Therapy
- BEHAVIORAL TAU
Study Locations (1)
Tennessee
- Vanderbilt University Medical Center - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2025-01-15 |
| Est. Completion | 2030-02-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06835556
The ClinicalTrials.gov registry entry for NCT06835556 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 116-participant average among 5 other Schizophrenia Disorders trials with a reported enrollment target. The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Schizophrenia Disorders appearing as the primary indexed condition, and to 2 interventions - of which Cognitive Behavioral Therapy is the first listed.
NCT06835556 reports 1 study location spanning 1 distinct geographic area - top geographies include Tennessee.
Frequently Asked Questions
What is clinical trial NCT06835556 about?
NCT06835556 is a clinical study titled "Volatility in Paranoia (VIP) Trial: An RCT of Changes in Volatility With Psychotherapy". The goal of this clinical trial is to learn whether learning and belief updating change in response to the treatment of persecutory delusions, in individuals with schizophrenia-spectrum disorders. The main questions are: 1. do prior expectations about environmental volatility reduce following effe...
What is the current status of trial NCT06835556?
This trial is currently recruiting. It is a NA study. The enrollment target is 120 participants. The study started on 2025-01-15. Estimated completion is 2030-02-01.
What conditions does trial NCT06835556 study?
This clinical trial studies the following conditions: Schizophrenia Disorders.
What interventions are being tested in trial NCT06835556?
The interventions under investigation include: Cognitive Behavioral Therapy (BEHAVIORAL), TAU (BEHAVIORAL).
Who is sponsoring clinical trial NCT06835556?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06835556 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Schizophrenia Disorders
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Visual Perception in Schizophrenia
RECRUITING · NA
-
Brain Stimulation to the Hippocampus in Schizophrenia
RECRUITING · NA
-
Activities to Change Your Mood: A Test of the Acceptability and Initial Efficacy in Clinical Samples and Healthy Controls
RECRUITING · NA
-
Randomized Clinical Trial of iTEST: A Blended Intervention Targeting Introspective Accuracy
RECRUITING · NA
-
White Matter Plasticity in Schizophrenia
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.